‘Knock out the middlemen’: A campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
pharmaphorum3y
FDA okays Viatris' insulin drug as first 'interchangeable' biosimilar
Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...
The Associated Press on MSN14d
Gov. Newsom committed California to making its own insulin. It’s at least a year behind his schedule
meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate prescription. The length of time it takes for a company to develop a drug, get FDA ...
pharmaphorum10y
Insulin glargine biosimilar approved in Europe
Lilly and Boehringer Ingelheim have gained EU approval for their biosimilar version of Sanofi's blockbuster insulin ... drug – and partly on how much cheaper its version is in comparison to Lantus.
Missoulian8hOpinion
Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.